TipRanks
Verrica Pharmaceuticals (VRCA)
NASDAQ:VRCA
US Market
Want to see VRCA full AI Analyst Report?

Verrica Pharmaceuticals (VRCA) Ratios

490 Followers

Verrica Pharmaceuticals Ratios

VRCA's free cash flow for Q2 2026 was $0.85. For the 2026 fiscal year, VRCA's free cash flow was decreased by $ and operating cash flow was $-2.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.45 2.59 1.76 4.55 11.31
Quick Ratio
1.33 2.45 1.68 4.49 11.31
Cash Ratio
0.50 1.83 1.60 4.09 9.91
Solvency Ratio
-0.96 -0.76 -1.18 -1.07 -5.07
Operating Cash Flow Ratio
-0.59 -1.07 -2.10 -2.27 -5.39
Short-Term Operating Cash Flow Coverage
0.00 0.00 -4.71 0.00 0.00
Net Current Asset Value
$ 929.00K$ 20.15M$ -12.81M$ 15.70M$ 34.43M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.03 0.85 0.56 0.03
Debt-to-Equity Ratio
0.42 0.07 -4.66 2.30 0.04
Debt-to-Capital Ratio
0.30 0.06 1.27 0.70 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 1.47 0.68 0.00
Financial Leverage Ratio
8.36 1.90 -5.49 4.13 1.12
Debt Service Coverage Ratio
-7.20 -1.21 -2.95 -15.70 -9.94
Interest Coverage Ratio
-7.54 -1.54 -7.00 -16.60 -9.80
Debt to Market Cap
0.00 0.00 1.21 0.13 0.00
Interest Debt Per Share
0.26 0.88 10.68 10.91 1.08
Net Debt to EBITDA
0.35 3.05 <0.01 0.39 1.52
Profitability Margins
Gross Profit Margin
85.89%90.33%63.79%85.44%91.97%
EBIT Margin
-90.53%-28.51%-887.75%-1230.15%-247.07%
EBITDA Margin
-88.61%-26.32%-870.98%-1213.84%-239.12%
Operating Profit Margin
-92.78%-33.56%-871.25%-1283.35%-235.78%
Pretax Profit Margin
-102.84%-50.27%-1012.15%-1307.47%-271.11%
Net Profit Margin
-102.84%-50.27%-1012.15%-1307.47%-271.11%
Continuous Operations Profit Margin
-102.84%-50.27%-1012.15%-1307.47%-271.11%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
110.85%149.81%116.17%101.88%114.98%
Return on Assets (ROA)
-86.58%-37.95%-141.46%-82.10%-54.76%
Return on Equity (ROE)
-444.44%-72.29%776.66%-338.99%-61.17%
Return on Capital Employed (ROCE)
-207.23%-38.90%-262.40%-101.84%-51.61%
Return on Invested Capital (ROIC)
-193.59%-37.97%-170.21%-100.74%-51.24%
Return on Tangible Assets
-86.58%-37.95%-141.46%-82.10%-54.76%
Earnings Yield
-31.96%-20.21%-211.16%-20.18%-26.06%
Efficiency Ratios
Receivables Turnover
2.73 6.59 98.26 1.16 18.55
Payables Turnover
2.67 1.66 1.45 0.30 1.43
Inventory Turnover
1.58 1.54 1.11 0.73 0.00
Fixed Asset Turnover
14.91 19.11 2.93 1.42 1.69
Asset Turnover
0.84 0.75 0.14 0.06 0.20
Working Capital Turnover Ratio
2.27 1.47 0.18 0.11 0.28
Cash Conversion Cycle
228.14 72.77 79.25 -390.97 -235.57
Days of Sales Outstanding
133.50 55.37 3.71 314.57 19.68
Days of Inventory Outstanding
231.44 237.18 328.10 500.04 0.00
Days of Payables Outstanding
136.80 219.78 252.57 1.21K 255.25
Operating Cycle
364.94 292.55 331.82 814.61 19.68
Cash Flow Ratios
Operating Cash Flow Per Share
-0.63 -1.65 -11.76 -8.51 -5.46
Free Cash Flow Per Share
-0.63 -1.65 -11.77 -8.59 -5.55
CapEx Per Share
0.00 0.00 <0.01 0.08 0.09
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 -2.26K -106.57 -61.75
Capital Expenditure Coverage Ratio
0.00 0.00 -2.26K -106.57 -61.75
Operating Cash Flow Coverage Ratio
-7.37 -10.81 -1.33 -0.85 -12.22
Operating Cash Flow to Sales Ratio
-0.44 -0.50 -8.05 -7.53 -2.06
Free Cash Flow Yield
-16.96%-19.91%-168.08%-11.73%-20.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.63 -4.95 -0.47 -4.95 -3.84
Price-to-Sales (P/S) Ratio
2.59 2.49 4.79 64.77 10.40
Price-to-Book (P/B) Ratio
22.66 3.58 -3.68 16.79 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
-5.89 -5.02 -0.59 -8.52 -4.96
Price-to-Operating Cash Flow Ratio
-7.31 -5.02 -0.60 -8.60 -5.04
Price-to-Earnings Growth (PEG) Ratio
-0.08 0.06 0.00 -0.05 0.09
Price-to-Fair Value
22.66 3.58 -3.68 16.79 2.35
Enterprise Value Multiple
-2.58 -6.41 -0.54 -4.95 -2.83
Enterprise Value
69.29M 60.01M 35.88M 307.87M 61.20M
EV to EBITDA
-2.58 -6.41 -0.54 -4.95 -2.83
EV to Sales
2.29 1.69 4.74 60.08 6.78
EV to Free Cash Flow
-5.19 -3.40 -0.59 -7.91 -3.23
EV to Operating Cash Flow
-5.19 -3.40 -0.59 -7.98 -3.28
Tangible Book Value Per Share
0.20 2.32 -1.90 4.36 11.72
Shareholders’ Equity Per Share
0.20 2.32 -1.90 4.36 11.72
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
1.42 3.34 1.46 1.13 2.64
Net Income Per Share
-1.46 -1.68 -14.78 -14.78 -7.17
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.14 1.76 1.14 1.06 1.10
Research & Development to Revenue
0.48 0.25 1.56 3.96 1.35
SG&A to Revenue
1.25 0.99 7.77 9.23 1.93
Stock-Based Compensation to Revenue
0.12 0.09 0.95 2.81 0.55
Income Quality
0.43 0.99 0.80 0.58 0.76
Currency in USD